Related Experiment Video
Updated: Jun 21, 2025

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
First-Generation OTC Antihistamine Use and Voice Function in Individuals with Allergic Rhinitis: A Preliminary Report
Rebecca J Hall-Landers1, Mariah E Morton-Jones2, Laura W Plexico1
1Department of Speech, Language, & Hearing Sciences, Auburn University, Auburn, Alabama.
Routine over-the-counter antihistamine use in allergic rhinitis patients showed no voice function changes but did reveal laryngeal mucosal changes, suggesting potential vocal fold adaptations.
Area of Science:
- Otolaryngology
- Allergology
- Speech-Language Pathology
Background:
- Allergic rhinitis commonly affects individuals, often managed with over-the-counter antihistamines.
- Laryngeal effects of routine antihistamine use in this population are not well-documented.
Purpose of the Study:
- To investigate the impact of Chlor-Trimeton on laryngeal structure and function.
- To study individuals with allergic rhinitis who routinely use antihistamines but report no voice disorders.
Main Methods:
- Prospective, within-participant, repeated measures design.
- Eight participants with allergic rhinitis and no voice disorder history completed measures before and after antihistamine intake.
- Measures included perceptual voice, phonation threshold pressure (PTP), acoustic analysis, and laryngeal imaging.
Main Results:
- No significant changes in acoustic or aerodynamic measures were observed.
- Laryngeal imaging revealed mucosal changes (increased vascularity, mucus, vocal fold color changes) consistent with 'allergy larynx'.
- Phonation threshold pressure remained stable.
Conclusions:
- Clinical observations of laryngeal tissue changes in allergic rhinitis are affirmed.
- Stable PTP suggests possible vocal fold cover adaptations to routine antihistamine use, potentially mitigating drying effects.
Related Concept Videos
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...

